Temple Lazenby, MD
Obstetrics & Gynecology · Dothan, ALNPI 1144252305
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 141 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 30.7% of the total. Reporting peaked in 2019 at $677 and has fallen 90.5% since, to $64 in 2025.
Across 141 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$778
- Hologic Sales And Service, LLC$318
- Astellas Pharma US Inc$252
- Pfizer$195
- Exeltis, USA Inc.$163
- Sumitomo Pharma America, Inc.$124
- plus $706 from 20 others
What the payments were for
- Food & beverage$2,528100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $778 |
| Hologic Sales And Service, LLC | 14 | $318 |
| Astellas Pharma US Inc | 16 | $252 |
| Pfizer | 15 | $195 |
| Exeltis, USA Inc. | 8 | $163 |
| Sumitomo Pharma America, Inc. | 4 | $124 |
| Mayne Pharma Commercial LLC | 6 | $122 |
| Scynexis, Inc. | 5 | $70 |
| Bayer | 4 | $59 |
| Therapeuticsmd, Inc. | 4 | $59 |
| Urovant Sciences Inc | 3 | $56 |
| Amgen | 4 | $48 |
| Myovant Sciences Inc. | 3 | $36 |
| Duchesnay USA Incorporated | 2 | $35 |
| Coopersurgical, Inc. | 2 | $29 |
| Millicent US Inc | 2 | $29 |
| Organon | 2 | $24 |
| Radius Health, Inc. | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $17 |
| Merck | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Coloplast | 1 | $15 |
| Lupin Inc. | 1 | $14 |
| Medtronic | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Agile Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,536 in reported general payments places this provider in the 65th percentile of 537 obstetrics & gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 26 | $800 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Dothan
- Praful PatelDothan$65K
- Theodore TsaltasBirmingham$853K
- Richard BrownGulf Shores$429K
- Timothy HughesMobile$149K
- Allison CalhounMobile$132K
- Angela McCool-PearsonFairhope$57K
- Tomeka RobertsBirmingham$44K
- Percy HudsonBirmingham$29K
- Heidi StraughnBirmingham$29K
- Francois BlaudeauHomewood$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.